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ABSTRACT   43 
Dietary nitrate (𝑁𝑂3
− ) supplementation has been associated with improved vascular and 44 
metabolic health. We conducted a double-blind, cross-over, placebo-controlled RCT to 45 
investigate the effects of 7-day consumption of beetroot juice compared with placebo on 1) 46 
blood pressure (BP) measured in resting conditions and during exercise, 2) cardiac and 47 
peripheral vascular function and 3) biomarkers of inflammation, oxidative stress and 48 
endothelial integrity.   49 
Twenty non-smoking healthy participants aged 60-75y and BMI 20.0-29.9kg/m
2
 were 50 
recruited. Measurement were conducted before and after each 7-day intervention period. 51 
Consumption of 𝑁𝑂3
− had no effect on resting systolic and diastolic BP. 𝑁𝑂3
− consumption 52 
did not improve indexes of central and peripheral cardiac function responses during 53 
cardiopulmonary exercise testing. Dietary 𝑁𝑂3
−  supplementation did not modify biomarkers 54 
of inflammation, oxidative stress and endothelial integrity. 55 
This study do not support the short-term benefits of dietary 𝑁𝑂3
− supplementation on 56 
physiological and biochemical markers of vascular health in older healthy adults. 57 
Trial Registration: ISRCTN19064955 58 
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INTRODUCTION 59 
Ageing is a primary risk factor for atherosclerosis and cardiovascular diseases (CVD)(North 60 
and Sinclair 2012). Cardiac ageing is characterised by prominent changes in cardiovascular 61 
tissues including hypertrophy, altered left ventricular (LV) diastolic function and cardiac 62 
output (CO), and increased arterial stiffness. In older adults, resting CO is preserved by an 63 
increase in LV end-diastolic volume with a consequent augmentation of stroke volume (SV). 64 
With the increase in energy demands during exercise, older adults achieve people a higher 65 
SV and mean arterial blood pressure but lower heart rate and peak oxygen consumption 66 
compared to younger subjects. Therefore, SV during exercise in older adults is preserved by 67 
an increase in end-diastolic volume whereas in younger subjects is maintained by a 68 
progressive decrease in end-systolic volume(Cheitlin 2003, Houghton et al. 2016). 69 
Augmentation index was significantly higher in older than younger participants and was 70 
inversely related CO in older participants [3]. 71 
Nitric oxide (NO) appears to have pleiotropic effects on cardiac physiology(North and 72 
Sinclair 2012), being produced by all myocardial cells and is involved in the regulation of 73 
coronary vasodilation and cardiomyocyte contractility(Massion et al. 2003). NO is 74 
synthesised by vascular and endocardial endothelial nitric oxide synthases (NOS), as well as 75 
neuronal and inducible NOS(Rastaldo et al. 2007). The effects of NO on myocardial 76 
contractility appear to be mediated by the opening of sarcolemmal voltage-operated and 77 
sarcoplasmic ryanodin receptor Ca(2+) channels(Rastaldo, et al. 2007). NO is also involved 78 
in the modulating post-ischemic cardiac remodeling infarction which may be mediated by a 79 
decreased mitochondrial permeability(Di Lisa et al. 2001).  80 
NO is involved in several other physiological functions such as maintenance of vascular tone, 81 
platelet adhesion, angiogenesis, mitochondrial oxygen consumption, muscular performance 82 
and control of immunity and inflammation signalling pathways (Kelm 1999). Inorganic  𝑁𝑂3
−  83 
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represents the final, stable end product of nitric oxide (NO) metabolism and it is mainly 84 
excreted in urine (~70%). Approximately 25-30% of circulating blood 𝑁𝑂3
−  enters a non-85 
enzymatic NO synthetic pathway involving salivary glands, oral microbiota and gastric acidic 86 
environment (Lundberg et al. 2009). Inorganic  𝑁𝑂3
−
 from food can also enter the non-87 
enzymatic NO pathway, increase NO production and induce positive effects on 88 
cardiovascular function and muscle performance(Lundberg, et al. 2009). The role of ageing 89 
as a modifier of the effects of inorganic  𝑁𝑂3
− on cardiovascular outcomes remains unknown. 90 
Convincing evidence on health benefits of dietary  𝑁𝑂3
−  on cardiovascular outcomes 91 
currently exists for young and middle-aged individuals (Gee and Ahluwalia 2016, Lara, 92 
Ashor, et al. 2015), whereas contrasting findings have been reported in older populations(Gee 93 
and Ahluwalia 2016, Lara, et al. 2015, Omar et al. 2016, Siervo et al. 2013). In addition, 94 
limited information is available on the effects of inorganic  𝑁𝑂3
−  consumption on cardiac 95 
function at rest and during exercise in healthy adults (DeVan et al. 2015, Lee et al. 2015) and 96 
in patients with heart disease (Eggebeen et al. 2016, Zamani et al. 2015).  97 
We hypothesise that dietary 𝑁𝑂3
− consumption can increase systemic NO bio-availability and 98 
have a positive effect on central and peripheral hemodynamic responses of healthy older 99 
adults measured at rest, during different exercise intensities (low, moderate and high) and 100 
post-exercise recovery. We evaluated the effects of beetroot juice, chosen as a rich source of 101 
dietary  𝑁𝑂3
− , on blood pressure (BP), augmentation index (AIx) and hemodynamic 102 
parameters of cardiac function including CO, stroke volume (SV), cardiac index (CI) and 103 
heart rate (HR) measured at rest and during graded exercise on a stationary bike. We also 104 
evaluated whether dietary 𝑁𝑂3
− consumption induced changes in circulating biomarkers of 105 
inflammation, oxidative stress and endothelial integrity to provide mechanistic insights into 106 
the effects of dietary 𝑁𝑂3
− on circulatory biomarkers closely involved in the regulation of 107 
vascular function.  108 
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METHODS  109 
The trial was approved by the North of Scotland Research Ethics committee (14/NS/0061) 110 
and conducted in accordance with the Declaration of Helsinki. Written informed consent was 111 
obtained from all participants. The study was a double-blind, cross-over, placebo-controlled 112 
RCT which took place between May and August 2014 across two sites (Newcastle upon Tyne 113 
and Sheffield). The duration of the each intervention was one week with a wash-out period 114 
between treatments of at least one week. This trial was registered in the International 115 
Standard Randomised Controlled Trial Number Register (ISRCTN19064955).  116 
Participants: Twenty older healthy people (10 male, 10 female) were recruited (10 117 
participants per site). Participants were included in the study if they did not have medical 118 
conditions or were not taking medications that might influence the study outcomes. A full list 119 
of the inclusion and exclusion criteria is provided in the Online Supplementary Material. 120 
Participants were asked to maintain their habitual diet and to avoid using chewing gum or 121 
mouth wash for at least 48 prior to the baseline visits (first and third visit) and during each of 122 
the one-week supplementation periods.  123 
Study Overview: A telephone screening was performed to check eligibility to the trial’s 124 
inclusion and exclusion criteria. Eligible participants were asked to arrive at the research 125 
facilities after a 12-hour overnight fast and having avoided strenuous physical activity for 126 
three days preceding the visit. Eligibility to the study was confirmed by measuring BMI, 127 
resting blood pressure and conducting a resting 12 lead electrocardiogram. Participants were 128 
randomised to a cross-over intervention and the assessment continued with the measurement 129 
of body composition and collection of blood and urine samples and the assessment of 130 
physical capability (reported elsewhere). Participants then rested for one hour and consumed 131 
a meal providing approximately 300kcal (CHO=85%, PRO=3%, FAT=12%). After the 1 132 
hour rest period the exercise test was explained to the participants and they and they became 133 
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accustomised to the bicycle ergometer. The exercise protocol is described in Figure S1 of the 134 
Online Supplementary Material. After the vascular measurements and the exercise test, 135 
instructions were provided for self-administration of the nutritional intervention (14 bottles of 136 
either 𝑁𝑂3
− -rich or 𝑁𝑂3
− -depleted beetroot juice; 70ml x 2/day; Beet It, James White Ltd, 137 
UK) and asked to consume one bottle of beetroot juice each morning and evening for the 138 
subsequent 7 days. The daily dose of 𝑁𝑂3
−-rich (intervention) or 𝑁𝑂3
− -depleted (placebo) 139 
beetroot juice contained ~12mmol and ~0.003mmol of 𝑁𝑂3
−, respectively. This concluded 140 
Visit 1 of the trial. Participants returned to the research facilities in the morning of day eight 141 
after they had completed a seven-day supplementation period. Measurements were conducted 142 
approximately after 12 hours from drinking the beetroot juice as participants were asked to 143 
fast overnight before arriving to the research centre. The resting 12 lead ECG was performed 144 
and if normal the visit continued with a repeat of the assessments performed at visit 1. At the 145 
end of the second visit, participants were asked to resume their habitual diet and physical 146 
activity. After a wash out period of at least seven days the second phase (including Visits 3 147 
and 4) was conducted similar to the first phase with the exception that participants crossed-148 
over experimental arms i.e. consumed the other intervention agent.  149 
Resting and Daily Blood Pressure: Resting BP was measured in triplicate using an automated 150 
BP monitor (Omron M3, Omron Healthcare, UK) at each clinic visit with the participant 151 
seated comfortably for 15 min prior to the measurement and the arm supported at the level of 152 
the heart. The same BP monitor (Omron M3, Omron Healthcare, UK) was provided to each 153 
participant for the measurements of daily resting BP at home. Participants were asked to 154 
conduct duplicate measurements in a seated position in the morning before drinking the juice 155 
and in the evening before going to bed. Agreement of the daily BP monitoring was verified 156 
against the BP recordings obtained from the 24-hr ABPM (systolic BP, r=0.71, p<0.001, 157 
n=84; diastolic BP, r=0.80, p<0.001, n=84)(Jajja et al. 2014). 158 
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Resting and exercise central hemodynamics: All subjects performed a maximal graded 159 
cardiopulmonary exercise test using an electro-magnetically controlled bicycle ergometer 160 
(Corival, Lode, Groningen, Netherlands) with online gas exchange measurements (Metalyzer 161 
3B, Cortex, Leipzig, Germany). The maximal progressive exercise test included cycling with 162 
10-watt increments every minute until volitional exhaustion. The 12-lead ECG (Custo, 163 
CustoMed GmbH, Ottobrunn, Germany) was continuously monitored and blood pressure 164 
(Tango, SunTech Medical, Morrisville, NS, USA) recorded at rest, during exercise and 165 
recovery (Newcastle Centre only, N=10). The test was terminated when the subject was 166 
unable to pedal at a cadence of 50 revolutions per minute or they reached maximal oxygen 167 
consumption. Peak oxygen consumption was defined as the average oxygen uptake during 168 
the last minute of exercise. Non-invasive central hemodynamics parameters (SV, CO and CI) 169 
were measured by bioreactance method (NICOM, Cheetah Medical, Deleware, 170 
USA).(Jakovljevic 2014) CO was estimated under resting and exercise stress testing 171 
conditions using the bio-reactance method which analysis the frequency of relative phase 172 
shifts of electrical current applied across the thorax using four dual-surface electrodes. 173 
Signals were applied to and recorded from the left and right sides of the thorax; these signals 174 
are processed separately and averaged after digital processing. The signal processing unit of 175 
the system determines the relative phase shift between the input signal relative to the output 176 
signal. The phase shift occurs due to instantaneous changes in blood flow in the aorta. 177 
Cardiac output is subsequently estimated as the product of stroke volume and heart rate. 178 
Cardiac Index (CI) is calculated by adjusting the CO for body surface area. A graphical 179 
description of the protocol is described in Figure S2 of the Online Supplementary 180 
Material. 181 
Augmentation Index:  A high fidelity micro-manometer was used to apply a gentle pressure 182 
and therefore flatten the radial artery in the non-dominant hand at the wrist under resting 183 
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condition using the SphygmoCor (AtCor Medical, NSW, Australia). Central aortic pressure 184 
and augmentation index was then calculated automatically using the SphygmoCor software. 185 
AIx was calculated as the difference between the first systolic peak and the second systolic 186 
peak of the central arterial waveform, which was expressed as a percentage of pulse pressure.  187 
Anthropometry, Dietary and Lifestyle Questionnaires: Body weight and height were 188 
measured to the nearest 0.1 kg and 0.5 cm, respectively. The 9-item short form of the 189 
International Physical Activity Questionnaire (IPAQ) was used to record levels of physical 190 
activity: 1) vigorous-intensity activity 2) moderate-intensity activity, 3) walking and 4) 191 
sitting. A combined total physical activity score was calculated and expressed in MET-192 
minutes/week(CRAIG et al. 2003). The EPIC Food Frequency Questionnaire (FFQ) was 193 
administered at baseline and the FETA software used to extract dietary (energy and nutrient) 194 
information(Mulligan et al. 2014).  195 
Blood and Urine Collection: Fasting blood samples were collected at the beginning of each 196 
visit and centrifuged at 3,000rpm for 10 min at 4 °C within 30min of collection. Aliquots of 197 
plasma and serum were frozen and stored at –80 °C for subsequent analyses. Mid-stream 198 
urine samples were collected, in fasting conditions, into sterile containers and stored at –20 199 
°C for subsequent analyses. 200 
Biomarker Analysis: A modified version of the gas chromatography mass spectrometry (GC-201 
MS) method proposed by Tsikas et al(Tsikas 2000) was used to determine 𝑁𝑂3
− and 𝑁𝑂2
− 202 
concentrations in urine and plasma samples and sum of 𝑁𝑂3
− and 𝑁𝑂2
− (NOx) was calculated. 203 
However, blood samples were not immediately processed (~30-45 minutes) to preserve 𝑁𝑂2
− 204 
and therefore 𝑁𝑂3
− is the main contributor to the total concentration of NOx. The protocol 205 
and validation of the modified GC-MS method have been described elsewhere(Qadir et al. 206 
2013). Methods for the measurement of glucose, insulin, IL-6, 3-NT, cGMP, ET-1, P-207 
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selectin, E-Selectin, intercellular adhesion molecule-3 (ICAM-3) and thrombomodulin are 208 
reported in the Online Supplementary Material.   209 
Statistical Analysis: Repeated-Measures General Linear Models (GLM) were used to test the 210 
effect of 𝑁𝑂3
−  consumption on measures of vascular function and blood biomarkers. 211 
Treatment (nitrate vs placebo) was entered as a group factor (Tr) and the time points of the 212 
incremental exercise test as the repeated factor (Ti). Post-hoc comparison between treatment 213 
groups at each time point was performed using the Fisher LSD test. Analyses were conducted 214 
using Statistica 10 for Windows (StatSoft.Inc, Tulsa, OK, USA). Statistical significance was 215 
set at <0.05.   216 
RESULTS 217 
Participants’ characteristics and safety: Twenty participants were randomised to the 218 
interventions. One person developed an ischemic event during the physical exercise testing 219 
performed at the second visit and he was excluded from the study (Figure 1). The remaining 220 
19 participants (mean age 64.7±3.0 years) reported no side effects apart for the expected 221 
urine discoloration related to the excretion of beetroot juice pigment (beeturia). Baseline VO2 222 
max of participants was 23.6±5.8 ml/kg/min for men and 20.5±2.8 ml/kg/min for women. 223 
Body weight, dietary Intake and self-reported physical activity: Mean baseline BMI was 224 
25.6±3.4 kg/m
2
. Body weight did not change during the study in either groups (p=0.51) 225 
(Table S1 of the Online Supplementary Material). Changes in self-reported physical 226 
activity were again not different between the placebo and the 𝑁𝑂3
− arms (p=0.99) (Table S1 227 
of the Online Supplementary Material). 228 
Resting Clinic and Daily Blood Pressure: Baseline resting systolic and diastolic BP were 229 
127.4 ± 16.1 mmHg (range: 100.0 – 168.0 mmHg) and 76.2 ± 9.6 mmHg (range: 61.6 – 95.7 230 
mmHg), respectively. Clinic systolic BP were not significant after 𝑁𝑂3
−  consumption 231 
compared to placebo (-5.05±9.45 vs -2.64±9.04 mmHg respectively, p=0.42) (Figure 2a). 232 
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Similarly, daily BP was not significant for both systolic (p=0.75) and diastolic (p=0.63) 233 
readings measured over the 7-day period (Figure 2b). 234 
Augmentation Index: 𝑁𝑂3
−  consumption did not have a significant effect on AIx (p=0.87, 235 
Figure S3).  236 
Blood Pressure and Cardiac Function during Standardised Exercise: 𝑁𝑂3
−  consumption did 237 
not influence systolic BP response (p=0.92, Figure 3a) during exercise whereas a non-238 
significant trend for lower diastolic BP after NO3
− supplementation (p=0.08, Figure 3b). 239 
Specifically, lower diastolic BP readings were recorded during moderate sub-maximal 240 
exercise intensities (work rate: 40W, 60W and 80W). Dietary 𝑁𝑂3
−  consumption did not 241 
modify parameters of cardiac function (CO, HR, SV and CI) measured at rest, during 242 
exercise and post-exercise recovery (Figure 4a-d). In addition, one week dietary 𝑁𝑂3
−  243 
consumption did not modify the association between CO and oxygen consumption (VO2) 244 
(nitrate, B±SE= 6.04±0.34, R
2
=0.60, p<0.001; placebo, B±SE= 6.68±0.42, R
2
=0.55, p<0.001) 245 
measured at different levels of exercise intensities (Figure S4 of the Online Supplementary 246 
Material).  247 
Laboratory Biomarkers: Concentrations of nitrite plus nitrate (𝑁𝑂2
−+𝑁𝑂3
−, NOx) in plasma 248 
and urine increased after 𝑁𝑂3
−  consumption by 150±77% and 979±488% compared to 249 
placebo (-9±33% and -13±34%, respectively). 𝑁𝑂3
−  consumption did not modify 250 
concentrations of fasting glucose (p=0.41), insulin (p=0.95) and HOMA-IR (p=0.88). 𝑁𝑂3
− 251 
consumption also did not induce any changes in biomarkers of endothelial function (cGMP, 252 
endothelin-1, E-Selectin, P-Selectin, thrombomodulin and ICAM-3), inflammation (IL-6) and 253 
oxidative stress (3-NT) (Table 1).  254 
DISCUSSION 255 
This study does not support a beneficial effect in the short-term of dietary 𝑁𝑂3
−ingestion on 256 
cardiac and peripheral vascular health in older healthy adults. In particular, a lack of effect 257 
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was observed for BP and central hemodynamic responses measured both at rest and during 258 
increased metabolic demands. These physiological measurements were complemented by a 259 
panel of circulating biomarkers of metabolic control, oxidative stress and endothelial 260 
integrity. None of these measurements were altered by one-week dietary  𝑁𝑂3
− ingestion, 261 
which stimulate further discussion on uncovering the factors that may explain the lack of 262 
efficacy in older populations and the contrast with the more consistent beneficial effects 263 
observed in younger populations.  264 
Extensive work has been conducted in the last decade to test the effects of dietary 𝑁𝑂3
− on 265 
BP but, despite numerous trials, the evidence is still limited due to the small sample size and 266 
short duration of completed trials(Gee and Ahluwalia 2016, Khatri et al. 2016, Mills et al. 267 
2016, Siervo, et al. 2013). Further research is especially needed in older populations, 268 
although patients with comorbidities such as peripheral arterial disease or heart failure (HF) 269 
appear to receive greater health benefits from dietary 𝑁𝑂3
−  consumption(Eggebeen, et al. 270 
2016, Kenjale et al. 2011, Zamani, et al. 2015). However, DeVan et al(DeVan, et al. 2015) 271 
have recently reported that sodium nitrite supplementation was well-tolerated and improved 272 
endothelial function and lessens carotid artery stiffening in middle-aged and older adults. 273 
Conversely, our group has recently reported non-significant effects of dietary  𝑁𝑂3
− 274 
consumption on endothelial function and on 24-hr ambulatory blood pressure (BP) in older 275 
adults with and without type 2 diabetes (>60years)(Lara, Ogbonmwan, et al. 2015, Siervo et 276 
al. 2015). These results have also recently been corroborated by Bondonno et al who found 277 
no effect of seven-day dietary 𝑁𝑂3
− consumption on home and 24-hr ambulatory BP in 278 
patients with raised BP (age range: 30-70y)(Bondonno et al. 2015, Bondonno et al. 2014). 279 
However, Kapil et al showed that a four-week intervention in drug-naïve hypertensive 280 
subjects (age range: 18-85y) significantly reduced clinic, home and 24-hr ambulatory BP and 281 
improved endothelial function(Kapil et al. 2015). The divergence of results is again part of 282 
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the discussion around the effects of dietary 𝑁𝑂3
−  on health outcomes and priority is now 283 
being assigned to the identification of factors accounting for the mixed findings. These 284 
factors may include phenotypic characteristics (i.e., age, BMI, health status) of the 285 
populations, dose of dietary nitrate and duration of supplementation, study design, 286 
measurement protocols of BP an vascular health, type of cardiopulmonary fitness test 287 
protocols. The dynamic BP responses during exercise have been investigated in young, 288 
healthy populations(Bond et al. 2014, Lee, et al. 2015) and in patients with COPD(Berry et 289 
al. 2015) and HF(Coggan et al. 2015, Coggan and Peterson 2016, Eggebeen, et al. 2016). In 290 
healthy young populations, two studies reported a decline of sub-maximal systolic BP after 291 
acute (single dose) and short-term (15 days) dietary 𝑁𝑂3
− consumption (Bond, et al. 2014, 292 
Lee, et al. 2015). In older COPD patients, dietary 𝑁𝑂3
− decreased systolic BP at rest whereas 293 
only diastolic BP showed a significant decline during 5W pedaling and 75% of maximal 294 
work rate(Berry, et al. 2015). In patients with HF, acute dietary 𝑁𝑂3
− did not improve BP 295 
responses during knee extension or cycle ergometry tests at sub-maximal and maximal 296 
efforts(Coggan and Peterson 2016). However, one week of daily dosing with dietary 𝑁𝑂3
− 297 
significantly improved submaximal BP in elderly patients with HF with preserved ejection 298 
fraction(Eggebeen, et al. 2016). Our study is the first trial to investigate resting and dynamic 299 
BP responses in older healthy adults and our results do not support a beneficial effect of 300 
dietary𝑁𝑂3
−on oxygen consumption (data not shown) as well as vascular responses during 301 
exercise. Precisely why there is a lack of response to dietary 𝑁𝑂3
− in our study is not known 302 
since we have supplemented subjects for one week and administered a 𝑁𝑂3
−  dose 303 
considerably higher compared to other studies (>700mg/day). The factors explaining these 304 
divergent age-dependent responses are still largely undetermined, which could potentially be 305 
related to a decline in the reducing capacity to convert 𝑁𝑂3
−  into 𝑁𝑂2
−  or sensitivity of 306 
cellular targets to NO. 307 
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In mice,  𝑁𝑂3
−consumption have been showed to increase the expression of calcium handling 308 
proteins in the heart, resulting in increased cardiomyocyte calcium signaling and improved 309 
left ventricular contractile function(Pironti et al. 2016). These findings have provided 310 
preliminary support to the role of dietary 𝑁𝑂3
−  as a cardiac modulator, which have then been 311 
translated into clinical interventions in populations without and with impaired cardiac 312 
function. In healthy populations, acute dietary 𝑁𝑂3
− consumption did not modify resting or 313 
sub-maximal CO(Bond, et al. 2014) whereas an improvement of CO and SV was observed 314 
after a one-week dietary 𝑁𝑂3
−consumption(Lee, et al. 2015). The only study testing the acute 315 
effects of dietary 𝑁𝑂3
− on cardiac function in HF patients with preserved ejection fraction 316 
found greater reductions in systemic vascular resistance, aortic augmentation index and 317 
increased CO during exercise(Zamani, et al. 2015). We tested whether dietary 𝑁𝑂3
−
 could 318 
minimise the age-related decline in myocardial contractility and ejection fraction, which 319 
could prompt compensatory myocardial cardiac hypertrophy(North and Sinclair 2012). This 320 
enhances in the short-term CO but the long-term effect of LV hypertrophy are known as 321 
represents an important step in the development of HF and coronary syndromes(Gosse 2005). 322 
Our scope was to evaluate whether dietary 𝑁𝑂3
−  could represent an effective and simple 323 
nutritional intervention that may minimise age-related changes in cardiac function and 324 
impact, from a primary prevention perspective, on the risk for HF. However, these 325 
preliminary results may not support the beneficial effects of dietary 𝑁𝑂3
− on cardiac function 326 
in older healthy populations but, if confirmed in more robust trials, dietary 𝑁𝑂3
− may still 327 
represent a promising nutritional strategy in patients with impaired cardiac function.  328 
The small sample size and the short duration are important limitations of this trial and a 329 
cautious interpretation of the results is needed; nevertheless, our study is to date one of the 330 
longest trials testing the effects of dietary 𝑁𝑂3
−  on resting and exercise vascular responses in 331 
older participants. We did not assess daily dietary intake during the trial. However, 332 
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participants were asked to maintain their habitual dietary intake during the study and the 333 
differences in nitrate intake between intervention and placebo groups were clearly 334 
demonstrated by the large differences in plasma and urinary nitrate concentrations. Plasma 335 
𝑁𝑂2
− concentrations were not measured since it was not possible due to logistic constraints to 336 
process the samples immediately after collection to minimise the immediate 𝑁𝑂2
− degradation 337 
(half-life: ~5 minutes). However, in previous studies testing the effects of dietary 338 
𝑁𝑂3
− consumption in older participants where plasma 𝑁𝑂2
− concentration was measured, an 339 
increase in plasma 𝑁𝑂3
− and NOx concentrations similar to the amount observed in this study 340 
occurred alongside a significant rise in plasma 𝑁𝑂2
− concentrations(Gilchrist et al. 2013). In 341 
addition, the measurement of NOx was critical to assess the compliance to the interventions 342 
as well as the attainment of a significant rise in plasma 𝑁𝑂3
− to enable an increased NO 343 
generation via the NO non-enzymatic pathway. Finally, the limitations of bio-reactance for 344 
the assessment of cardiac hemodynamic profiles have to be taken into account for the 345 
interpretation of the results. 346 
Testing the efficacy of dietary 𝑁𝑂3
− consumption on cardiovascular health is an attractive 347 
research area due to the potential use of natural products to increase 𝑁𝑂3
−   intake and 348 
applicability in long-term dosing. However, this short term intervention showed that dietary 349 
𝑁𝑂3
− consumption did not modify physiological and biochemical markers of vascular health 350 
in healthy older adults. However, these findings are preliminary and require corroboration in 351 
studies with longer duration and larger samples of healthy older individuals as well as in 352 
older patients with increased cardiovascular risk. 353 
 354 
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FIGURE LEGENDS 
Figure 1: Plasma and urinary nitrate after either 7-day consumption of nitrate-rich or nitrate-depleted 
beetroot juice. Data presented as mean±1SE. 
Figure 2: Resting (Panel A) and daily (Panel B) systolic and diastolic blood pressure (BP) measured during 
a one week oral consumption (End) with either nitrate-rich or nitrate-depleted beetroot juice. Data presented 
as mean±SEM.  SBP= systolic blood pressure; DBP= diastolic blood pressure.  
Figure 3: Systolic (Panel A) and diastolic (Panel B) blood pressure (BP) at rest, during incremental exercise 
and post-exercise recovery after one week oral consumption with either nitrate-rich or nitrate-depleted 
beetroot juice. Data presented as mean±SEM.   
Figure 4: Heart rate (Panel A), stroke volume (Panel B), cardiac output (Panel C) and cardiac index (Panel 
D) at rest, during incremental exercise and post-exercise recovery after one week oral consumption with 
either nitrate-rich or nitrate-depleted beetroot juice. Data presented as mean±SEM.   
 
